Prior studies investigated autoantibody responses to the large N-terminal domain of Nogo-A and showed that Nogo-A IgM antibodies were significantly increased in patients with MS and other neurological diseases, but not in systemic autoimmune diseases and healthy controls [64]. Here, CD40LG is linked to nervous system disorder.